Actively Recruiting
Study of Fatigue and Muscle Effects in Adults with Severe Axial Spondyloarthritis Starting Targeted Therapy
Led by University Hospital, Strasbourg, France · Updated on 2026-03-12
122
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the relationship between fatigue and skeletal muscle impact in people with severe axial spondyloarthritis SpA, a common inflammatory rheumatism affecting about 1% of the population. Fatigue is a major symptom in SpA, often reaching severe levels, and it is linked to reduced muscle strength and mass. This study aims to better understand how muscle changes contribute to fatigue and how these factors evolve with targeted therapy. Participants will undergo various assessments including aerobic exercise testing on a cycloergometer, measurements of muscle mass using two-photon absorptiometry, tests of isometric muscle strength, blood sampling to measure cytokine levels, evaluations of sedentary behavior, psychological impact, and fatigue levels. The study groups include patients starting targeted therapy with either severe or mild fatigue, with therapy initiation within 15 days before inclusion. During the study, participants will be monitored for oxygen consumption capacity at inclusion and undergo repeated measures to track changes in fatigue and muscle impact under treatment. Researchers will carry out detailed physical and laboratory evaluations, including ECG monitoring during exercise tests. The total participation duration extends until the study end date in December 2029, with comprehensive data collection to understand the fatigue and muscle dynamics in axial spondyloarthritis.
CONDITIONS
Brief Title
Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis
Research Team
A
Alain MEYER, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here